glp 1 cardiovascular disease GLP-1: A Game-Changer for Heart Health in Obesity GLP-1 receptor agonists and cardiovascular

When blood sugar levels drop quickly, it can lead to changes in blood flow that may predispose certain individuals to ischemic damage in the optic nerve

doi: 10.1210/en.2011-0174

This confirms that the discomfort is a titration-phase phenomenon for most people, not a permanent feature of the drug

doi: 10.1016/j.jhep.2021.05.025 64

Melanogenesis efficiency is still reduced when dosing against falling cortisol, meaning you may need higher cumulative doses over time to achieve the same pigmentation depth as morning-dosed protocols

Dihexa, a novel synaptogenic compound, enhances cognitive function in animal models of Alzheimer's disease